Abstract Background Coronavirus disease (COVID–19) has resulted in the death of more
than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …

The new respiratory infectious disease coronavirus disease 2019 (COVID-19) that
originated in Wuhan, China, in December 2019 and caused by a new strain of zoonotic …

Background: Critically ill patients with COVID-19 may develop multiple organ dysfunction
syndrome, including acute kidney injury (AKI). We report the incidence, risk factors …

Международный регистр АКТИВ представляет подробную характеристику
амбулаторных и госпитальных пациентов с COVID-19 евразийского региона. При …

Abstract SARS-CoV-2, the causative agent of COVID-19, primarily affects the epithelial
compartment in the upper and lower airways. There is evidence that the microvasculature in …

The international AKTIV register presents a detailed description of out-and inpatients with
COVID-19 in the Eurasian region. It was found that hospitalized patients had more …

Abstract Background Remdesivir (RDV) is US FDA approved for coronavirus disease 2019
(COVID-19) but not recommended in severe renal impairment (SRI, Creatinine clearance< …

Background Although coronavirus disease 2019 (COVID-19) patients who develop in-
hospital acute kidney injury (AKI) have worse short-term outcomes, their long-term outcomes …

Objectives Acute kidney injury (AKI) is associated with increased mortality among
coronavirus disease 2019 (COVID-19) patients. This meta-analysis aimed to identify risk …

Abstract Background and Objectives: The recent worldwide pandemic of COVID-19 has
been a serious, multidimensional problem that has left a detrimental worldwide impact on …